Literature DB >> 3335059

Evidence for increased aortic plasma membrane calcium transport caused by experimental atherosclerosis in rabbits.

S A Strickberger1, L N Russek, R D Phair.   

Abstract

Several lines of evidence, including the reported ability of calcium channel blockers to prevent atherogenesis in cholesterol-fed rabbits, suggest that calcium mediates one or more of the pathologic changes in atherosclerosis. Moreover, it has long been known that calcium accumulates in atherosclerotic blood vessels. To test the hypothesis that a substantial fraction of this accumulated calcium is intracellular and to identify possible causes of this accumulation, calcium fluxes and contents were determined in aortic segments from cholesterol-fed rabbits and age-matched controls. A new method, based on 45Ca efflux experiments and computer-assisted kinetic analysis, was used to measure intracellular and extracellular calcium contents (nmol calcium/g wet wt tissue) and fluxes. Total intracellular calcium increased from 269 +/- 11.6 to 1,300 +/- 352 nmol/g in cholesterol-fed animals compared with controls (p less than 0.01). This change was sufficient to account for the observed increase in total tissue calcium from 4,190 +/- 211 to 5,240 +/- 477 nmol/g (p less than 0.05). Thus, the fraction of tissue calcium that is intracellular increased significantly from 0.065 +/- 0.006 to 0.223 +/- 0.048 (p less than 0.01) in experimental atherosclerosis. In addition, the data were quantitatively consistent with the hypothesis that these changes are brought about by a 4.8-fold increase in the plasma membrane calcium permeability of aortic smooth muscle cells. These results provide evidence that increased intracellular calcium is a possible mediator of cholesterol-induced atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335059     DOI: 10.1161/01.res.62.1.75

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  7 in total

Review 1.  Antiatherogenic effects of calcium-channel blockers: possible mechanisms of action.

Authors:  P D Henry
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

2.  Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells.

Authors:  S Allen; S Khan; F Al-Mohanna; P Batten; M Yacoub
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

3.  Effects of 17 β-estradiol on lipopolysacharride-induced intracellular adhesion molecule-1 mRNA expression and Ca²+ homeostasis alteration in human endothelial cells.

Authors:  Der Thor; Rui Zhang; Leigh Anderson; Diptiman D Bose; Gregory P Dubé; Roshanak Rahimian
Journal:  Vascul Pharmacol       Date:  2010-09-16       Impact factor: 5.773

4.  Cholesterol enrichment increases basal and agonist-stimulated calcium influx in rat vascular smooth muscle cells.

Authors:  R A Bialecki; T N Tulenko; W S Colucci
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

5.  Mevalonate availability and cardiovascular functions.

Authors:  J B Roullet; H Xue; A S Pappu; C Roullet; S Holcomb; D A McCarron
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

Review 6.  Concept of an antiatherosclerotic efficacy of calcium entry blockers. INTACT Investigators.

Authors:  S Jost; W Rafflenbeul; J Deckers; B Wiese; H Hecker; P Nikutta; P Lippolt; P Lichtlen
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

Review 7.  Abnormal cell calcium homeostasis in type 2 diabetes mellitus: a new look on old disease.

Authors:  J Levy
Journal:  Endocrine       Date:  1999-02       Impact factor: 3.925

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.